Skip to main content

Table 1 Baseline clinical characteristics of participants from GHS (N = 356)

From: Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes

Males (%)

67.4

Age (years)

64.5 ± 8.2

Smokers (%)

63 (17.7)

BMI (kg/m2)

30.2 ± 4.8

HbA1C (%)

8.6 ± 1.9

Total cholesterol (mg/dl)

176.0 ± 45.8

HDL-cholesterol (mg/dl)

43.6 ± 14.6

Tryglicerides (mg/dl)

152.3 ± 91.8

Insulin w/wh oral agents (%)

192 (54.0)

Hypertension (%)

302 (84.8)

HMW-adiponectin (µg/ml)

3.1 ± 2.5

Total adiponectin (µg/ml)

4.9 ± 2.9

  1. Continuous variables were reported as mean ± SD whereas categorical variables as total frequency and percentages
  2. GHS Gargano heart study, BMI body mass index, HbA1c glycated haemoglobin A1c HDL-cholesterol high density lipoprotein-cholesterol, HMW-adiponectin high molecular weight-adiponectin